|
Monday, 23 March 2009 08:54 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2007117331, WO 2007117331 | A new DNA polymerase from Thermoanaerobacter tengcongensis having a specific amino acid sequence; useful for procedures requiring strand-displacing DNA synthesis and for reverse transcription. | GE Healthcare Biosciences (Piscataway, NJ, USA) | Fuller CW, Hamilton S, Sundaram S | 12/22/2005 | 10/18/2007, 5/22/2008 | | WO 2008044339 | A DNA synthesis inhibitor in retinal vascular endothelial cells for treating age-related macular degeneration, vitreous hemorrhage, macular edema, premature retinopathy or uveitis; contains fat-soluble statin or its salt or solvate. | Aqumen Biophamaceuticals (Fukuoka City, Japan), Kyushu University (Fukuoka City, Japan) | HataY, Ishibashi T, Iwaki H, Kagimoto T | 10/13/2006 | 4/17/2008 | | WO 2007059330, WO 2007059330 | New cubane nucleoside analog compounds that are viral DNA synthesis inhibitors; useful for treating viral infection, for example, hepatitis B, hepatitis C, HIV-1, herpes simplex viruses (HSV)-1, HSV-2, Epstein-Barr viral infection and cancer. | Medkura (Fairfield, NJ, USA) | Murphy RB, Trampota M | 11/17/2005 | 5/24/2007, 12/21/2007 | | US 2007026469 | A method for generating a DNA molecule by coupling the hybridized oligonucleotides comprising at least one nonnatural nucleotide to form a first nucleotide strand and synthesizing a first complement to the first nucleotide strand. | EraGen Biosciences (Madison, WI, USA) | Prudent JR | 4/7/2006 | 11/15/2007 | | WO 2007130967 | A new oligonucleotide primer comprising a 5' universal sequence, a 3' target-specific primer sequence or an extension sequence; useful for initiating polymerase-catalyzed DNA synthesis at a target region on a polynucleotide template. | Siemens Medical Solutions Diagnostics (Tarrytown, NY, USA) | Reynolds R | 5/1/2006 | 11/15/2007 | | WO 2007076461 | A new thermostable DNA polymerase from Thermus scotoductus having a specific amino acid sequence; useful for procedures requiring strand-displacing DNA synthesis, for DNA sequencing, reverse transcription and PCR. | GE Healthcare Biosciences (Piscataway, NJ, USA) | Fuller CW, Hamilton S, Rech R | 12/22/2005 | 7/5/2007 | | EP 1780289, JP 2007116999, US 20070141595 | A method for assaying Regenerating islet–derived family, member 4 (regenerating gene type 4) mRNA comprising using a primer and using the RNA transcript in turn as a template for DNA synthesis to amplify the RNA transcript in a chain-reaction. | Tosoh (Yamaguchi, Japan) | Hayashi T, Saito J, Une K | 10/28/2005 | 5/2/2007, 5/17/2007, 6/21/2007 | | US 20070134677, WO 2007070270 | Forming a biochemical molecule such as DNA, comprising exposing a substrate prepared for light-directed synthesis of abiochemical molecule to light to define active and inactive regions and disabling synthesis in the inactive region. | Wisconsin Alumni Research Foundation (Madison, WI, USA) | Cerrina F, Kim C | 12/9/2005 | 6/14/2007, 6/21/2007 | | US 20070128656 | A method of incorporating a fluorescent label during first-strand complementary DNA synthesis, comprising providing a primer with a fluorescent label attached to one end. | University of South Florida (Tampa, FL, USA) | Agrawal D, Gross WW | 6/26/2003 | 6/7/2007 | | WO 2007035489, AU 2006292482 | A method of inhibiting DNA synthesis and DNA repair in a cell, comprising providing a 2-carboxyaldehyde pyridine thiosemicarbazone compound, contacting the cell with the compound and exposing the cell to ionizing radiation. | US Dept. of Health and Human Services (Washington, DC, USA) | Camphausen K, Gius D, Tofilon P | 9/16/2005 | 3/29/2007, 3/29/2007 | | WO 2006006079, EP 1734985 | Inhibiting DNA synthesis, p44/p42 mitogen-activated protein kinase activation or tube formation in arterial endothelial cells, comprising contacting the arterial endothelial cells with ephrinB2. | Aqumen Biopharmaceuticals (Fukuoka City, Japan) | Fujisawa K, Hata Y, Ishibashi T, Kagimoto T | 4/5/2004 | 1/19/2006, 12/27/2006 | | WO 2005111209, JP 2005328709 | Performing high-speed PCR useful for gene expression analysis, involving carrying out PCR under a specific temperature change, using heat-resistant Thermococcus kodakaraensis DNA polymerase exhibiting higher speed for DNA synthesis. | Toyo Boseki (Osaka, Japan) | Nakajima T, Oka M, Segawa M | 5/18/2004 | 11/24/2005, 12/2/2005 |
|
|
Monday, 23 March 2009 08:52 |
| Patent number | Description | Assignee | Inventor | Priorityapplication date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | GB 2445213, DE 102007054065, US 20080160615, JP 2008161184 | In vitro flavonoid-rich tissue from Neomarica gracilis having antitumor activity, obtained from a tissue culture preparation, which alters flavonoid content of N. gracilis, where flavonoids-rich tissue comprises tectorigenin; useful as a cytostatic, antibacterial and/or fungicide. | Tatung Co., Tatung University, Tatung Holdings Co. (Taipei, Taiwan) | Chu T, Ho C | 12/29/2006 | 7/2/2008, 7/3/2008, 7/3/2008, 7/17/2008 | | US 20080160560 | A new in vitro resveratrol-rich callus tissue derived from Vitis thunbergii Sieb. et Zucc. induced in a tissue culture system containing one or more plant growth regulators; useful for callus induction and producing resveratrol. | Ho C, Kuo H | Ho C, Kuo H | 1/3/2007 | 7/3/2008 | WO 2008073331, US 20080152630 | A method for generating and expanding tissue-progenitor cells or mature tissue cells in culture,comprising culturing intact bone marrow or intact umbilical cord tissue in a cell differentiation medium. | Ginis I, Schwartz A, Shinar D, Shirvan M, Teva Pharmaceuticals (Petah Tikva, Israel and North Wales,PA, USA) | Ginis I,Schwartz A,Shinar D,Shirvan M | 12/7/2006 | 6/19/2008, 6/26/2008 | EP 1930411, WO 2008068776 | A method of preparing a three-dimensional tissue equivalent comprising a cellular sheet of cells,comprising culturing cells onto the surface of the porous scaffold or matrix; useful for therapy such as treating or dressing a wound. | Reliance Life Science (Mumbai) | Deshpande MS, Kuchroo PV, Manisha SD, Pralhad BW,Pushpa VK,Rao SH,Sitahmraju HR, Wangikar PB | 12/8/2006 | 6/11/2008, 6/12/2008 | | JP 2008106064 | An enhancer of tissue plasminogen activatorproduced by heat processing Bacillus natto culture solution; useful as a pharmaceutical or foodstuff for preventing thrombotic diseases. | Honda Trading KK (Tokyo), Sumi Y | Sumi Y | 9/28/2006 | 5/8/2008 | | JP 2008086509 | A composition for regenerating periodontal-tissue(e.g., gum) comprising a culture medium having acell suspension of human periodontal membranepositioned on the upper region and a chemotaxissubstance blended on the lower region of the medium. | Sun Medical KK (Morioka, Japan) | Munakata M, Tajima K, Tsuchiya Y | 9/29/2006 | 4/17/2008 | | CN 101152580 | A tissue-engineered skin manufacturing methodinvolving obtaining skin tissue, confecting anepidermal stem suspension with a specifiedconcentration, adding epidermal stem cells into atissue culture medium and carrying the cell viasubmerged culture. | Lu H | Lu HI, Wang X | 9/13/2007 | 4/2/2008 | | CN 101142897 | A method for inducing and tissue culturing ofadventitious Pseudostellaria root, comprisingculturing root callus in an induction culturemedium and culturing the root in solid culturemedium and then in liquid culture mediumcontaining phytohormones. | Shanghai Jiaotong University (Shanghai) | Gao X, Jia W,Zhao A | 11/8/2007 | 3/19/2008 | | CN 101138321 | Virus-free tissue culture and rapid propagation of sugarcane, comprising preparing a culture medium, selecting explant, sterilization, induction cultureof callus, differentiation culture, rooting cultureand transplantation. | Zhejiang Academyof Agricultural Sciences(Zhejiang, China) | Chen J, Jiang Y,Lu Y, Mu H, Xu G | 8/22/2007 | 3/12/2008 | | WO 2007139989 | A method for preparing a sample such as a cellular sample, tissue sample, cell culture or cellularextract for analysis by mass spectroscopy, involving treating the sample with a fixative and analysis-enhancing material at temperature. | Brigham andWomen's Hospital (Boston), Brandeis University (Waltham, MA, USA) | Agar JN, Agar NYR, Black PM | 5/26/2006 | 12/6/2007 |
|
|
Monday, 23 March 2009 08:51 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2008072209 | A method for identifying and/or quantifying a target analyte present in sample by contacting the analyte with a probe molecule immobilized on a support and detecting the fluorescence signal induced in the spectral emission region of the fluorophore bound to the analyte. | Consiglio Nazionale delle Ricerche–Istitutonazionale per la Fisica della Materia (Genoa, Italy), Fondazione Istituto Italiano di Tecnologia (Genoa, Italy) | Calabi F, Cingolani R, Pompa PP, Rinaldi R, Sabela S | 12/14/2006 | 8/21/2008 | | EP 1946843, US 20080184809 | A method for monitoring and measuring the volume of liquid dispensed from a liquid-dispensing system, involving using an optical housing unit to measure the volume of dispensed liquid while the liquid maintains a cylindrical or quasi-cylindrical jet shape. | Allegro Research (Dublin) | Franken C, Shvets I, Zawada TP, Shvets IV | 12/21/2006 | 7/23/2008, 8/7/2008 | | US 20080176229 | A method of predicting the likelihood that a patient who is a candidate for treatment with an endothelial growth factor receptor (EGFR) inhibitor will respond to treatment, comprising determining the expression level of the transcript of STAT5B, or its expression product, in cancer cells obtained from the patient. | Agus D, Baker J, Cronin M, Shak S | Agus D, Baker J, Cronin M, Shak S | 2/6/2004 | 7/24/2008 | | US 20080161206 | A nominal scale factor determination method useful for reading biopolymeric (e.g., polypeptide and nucleic acid) arrays, involving collecting nominal scale factors for multiple dyes based on a recorded program; useful in genomics and proteomics. | Connell SD, Corson JF, Ghosh S | Connell SD, Corson JF, Ghosh S | 12/23/2002 | 7/3/2008 | | US 20080156978 | An interface apparatus for a differential mobility spectrometry (DMS) analyzer having electrodes with a gap to which ions are focused toward the median of the gap before and/or after at least one DMS analyzer. | Ibrahim YM, Shvartsberg AA, Smith RD, Tang K | Ibrahim YM, Shvartsberg AA, Smith RD, Tang K | 12/29/2006 | 7/3/2008 | | WO 2008079407 | A method of comparing multiple mass spectra from different samples by using the daughter fragment mass spectrum to establish amino acid sequence data for identifying a peptide corresponding to a peak of interest in the single aligned mass spectrum. | Graves SW | Esplin MS, Graves SW, Thulin CD | 12/26/2006 | 7/3/2008 | | WO 2008079269 | A new set of descriptor genes combined into groups; useful for sub-categorizing breast cancers and identifying signals with bi- and multi-modal patterns across a set of high-throughput molecular data produced from biological samples. | Bugrim A, Nikolskaya T, Nikolsky Y | Bugrim A, Nikolskaya T, Nikolsky Y | 12/19/2006 | 7/3/2008 | | WO 2008074861, FR 2910455 | A method for forming nonaligned microcavities/microchannels, involving forming a shaft and/or trench in an amorphous or monocrystalline layer and annealing the layer in a hydrogenated atmosphere so as to transform the shaft and/or trench into two microcavities. | Commissariat à l'Énergie Atomique (Gif-sur-Yvette, France) | Barbe J, Barbe JC, de Crecy F, Dornel E, Eymery J | 12/21/2006 | 6/26/2008, 6/27/2008 | | JP 2008122347 | A method of immobilizing a protein on a conductive resin film having a light transmittance of predetermined wavelength; useful for preparing biosensors. | Sony (Tokyo) | Negishi M, Shimura J, Tokita Y | 11/15/2006 | 5/29/2008 | | WO 2008058332 | A method of diagnosing diabetes, complications associated with diabetes or a predisposition of a subject to develop diabetes by detecting a difference in the level of biomarkers in a biological sample to a statistically validated threshold. | Autogen Res. Pty. Ltd. (Brighton, Victoria, Australia) | Blangero J, Collier GR, Curran JE, Jowett JBM, Moses EK, Shields KA, Walder KR | 11/14/2006 | 5/22/2008 | | WO 2008053150 | A microfabricated device or its component that has a uniform nonwetting or nonabsorbing coating or surface modification formed at the surface by ionization or activation processing, to produce a surface energy value of less than 15 mNm-1. | P2I Ltd. (Abingdon, UK) | Coulson S | 10/28/2006 | 5/8/2008 |
|
|
Monday, 23 March 2009 08:50 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2008112283 | A method of predicting the responsiveness of a tumor to treatment for anti-androgen therapy for prostate cancer by determining the androgen responsiveness microRNA expression profile of the tumor and correlating it to the therapeutic treatment. | US Department of Health and Human Services (Washington, DC, USA) | Kim CH, Munroe D, Soto J, Wu X | 3/12/2007 | 9/18/2008 | | US 20080199871 | A method of determining the sequence of a nucleic acid polymer, comprising forming a complementary strand of the nucleic acid polymer and identifying a sequence of nucleotides in the nucleic acid polymer and/or in the complementary strand using a particle beam, where the nucleic acid polymer and/or the complementary strand is DNA or RNA. | ZS Genetics (Bryn Mawr, PA, USA) | Glover WR | 7/14/2004 | 8/21/2008 | | CN 101246520 | A protein compound identification method involving building a protein interaction un-digraph, inputting a group of protein interaction data and setting a permitted maximum din of a shortest distance between a protein peak and a threshold value tin, which is between 0 to 1. The weight of each edge in a network is calculated, where the edge weight is defined as number of a public neighbor peak of two peaks of the edge. A seed is selected, when a candidate seed queue does not empty, and the seed is expanded as an initial state of an identified protein compound. | Central South University (Changsha, China) | Li M, Wang J | 3/18/2008 | 8/20/2008 | | WO 2008096375 | A method for determining a susceptibility to prostate cancer comprising determining the presence or absence of polymorphic markers in a nucleic acid sample obtained from the individual. | Decode Genetics (Reykjavik, Iceland) | Gudmundsson J, Sulem P | 2/7/2007 | 8/14/2008 | | CN 101234813 | Biologically processing sewage by installing a micropore aeration plate on a barrier, fixing a dynamic film on the barrier and placing a sequencing batch biological film unit on the dynamic film. | Wuhan University of Science and Technology (Wuhan, China) | Li Y, Yao M, Zhang Z | 11/22/2007 | 8/6/2008 | | JP 2008175793 | A method of determining sugar chain arrangement using a mass spectrometer by cleaving sugar chains into fragments, subjecting them to mass spectrometry and comparing various sugar chain fragments spectra or calculated sugar chain arrangement data. | Lifix (Toyama, Japan) | Anyoji H, Kanazawa M | 1/16/2007 | 7/31/2008 | | US 20080166773 | A vector preparation comprising a double-stranded DNA molecule having 3'-termini, useful for preparing recombinant moleculeshaving only a single insert and for cloning PCR-amplified sequences. | Lucigen (Middleton, WI, USA) | Godiska R, Hermanson S, Mead DA, Schoenfeld TW | 1/8/2007 | 7/10/2008 | | WO 2008041002 | Pairwise sequencing of the first and second regions of a target double-stranded polynucleotide by carrying out an extension reaction, treating the first and second immobilized template strands and carrying out a second sequencing read. | Solexa (Saffron Walden, UK) | Fashena S, Ost T, Rigatti R | 10/6/2006 | 4/10/2008 |
|
User Rating :     / 1
|
Monday, 23 March 2009 08:48 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2008101667, US 20080249014 | A method of obtaining highly purified hydrophobic protein comprising extracting the retentate by microdiafiltration using a buffer-solution containing a detergent and subjecting the filtrate to hydroxyapatite column chromatography. | Baxter Healthcare SA (Wallisellen, Switzerland), Baxter International (Deerfield, IL, USA), Mitterer A, Tauer C | Mitterer A, Tauer C | 2/22/2007 | 8/28/2008, 9/19/2008 | | US 20080221026 | A method of manufacturing a nematode-extracted anticoagulant protein (NAP) drug substance comprising fermenting, recovering NAP from cells and cellular debris, and purifying the NAP drug substance away from contaminants. | Dendreon (Seattle) | Lidell J, Mendoza CB, Moss D | 5/15/2003 | 9/11/2008 | | US 20080221309 | A new biologically active recombinant antibody or biologically active recombinant antibody fragment, used diagnostically/prognostically, therapeutically, for imaging, and/or for affinity purification of proteins. | Pastorek J, Pastorekova S, Zavada J | Pastorek J, Pastorekova S, Zavada J | 3/11/1992 | 9/11/2008 | | WO 2008104606 | Producing multimers of immunoglobulins in a cultured cell by co-expressing heavy chain, light chain and J chain and the endoplasmic reticulum Golgi intermediate compartment (ERGIC)-53 protein and purifying the cell culture supernatant. | Fondazione Centro San Raffaele del Monte Tabor (Milan) | Anelli T, Sitia RM | 3/1/2007 | 9/4/2008 | | US 20080203351, CN 101241788 | A magnetic nanocrystal, where the surface of the nanocrystal is bonded with a biocompatible macromolecule and an alkyl-containing molecule simultaneously; useful, for example, in biological applications such as DNA/RNA, protein and cell separation and purification. | Institute of Chemistry, The Chinese Academy of Sciences (Beijing), Gao M, Hu F, Liu S, Lu X | Gao M, Hu F, Liu S, Lu X | 1/15/2007 | 8/28/2008, 8/13/2008 | | WO 2008097870, US 20080206262 | A method for increasing the effectiveness of antigen presentation comprising isolating and purifying a dendritic cell asialoglyco protein receptor (DC-ASGPR)-specific antibody or its fragment. | Baylor Research Institute (Dallas) | Banchereau JF, Li D, Oh S, Zurawski G, Zurawski S | 2/2/2007 | 8/14/2008, 8/28/2008 | | WO 2008097829 | Producing an active mammalian N-acetylglucosaminyltransferase I (GnT1) protein in bacteria comprising expressing the mammalian GnT1 protein in bacteria and solubilizing, refolding and purifying the soluble mammalian GnT1 protein. | Neose Technologies (Horsham, PA, USA) | Johnson KF, Schwartz MF, Wu B | 2/2/2007 | 8/14/2008 | | WO 2008091740, US 20080193981 | A method for purifying antibodies comprising adjusting the acidity or salt concentration of a mixture containing an antibody, adding a negatively or positively charged polyelectrolyte, and separating the protein-polyelectrolyte precipitate. | Genentech (So. San Francisco, CA, USA), Fahrner RL, Franklin J, McDonald P, Peram T, Sisodiya V, Victa C | Fahrner RL, Franklin J, McDonald P, Peram T, Sisodiya V, Victa C | 1/22/2007 | 7/31/2008, 8/14/2008 | | CN 101195651 | A method of protein concentration/purification comprising using the difference between the charge properties of protein and amino acid ions under the action of an electric field and through gel crossover to move the protein from one container to another. | Guilin Medical College (Guangxi, China) | Chen S, Chou X, Li S, Lu M, Shi W | 6/8/2007 | 6/11/2008 | | CN 101157059 | A non-aperture amphoteric ion-exchange biological separating medium used for separating and purifying protein, enzyme and products. | Ningxia University (Yinchuan, China) | Gong B | 8/15/2007 | 4/9/2008 | | EP 1876183, WO 2008003707 | New factor VIII ligand peptide compounds useful for producing, labeling, detecting, diagnosing, monitoring, identifying, isolating, purifying, stabilizing and/or enhancing the activity of factor VIII or VIII-like protein and treat hemophilia A. | Technische Universitat Munchen (Munich) | Hauser C, Kessler H, Khrenov A, Knoer S, Saenko E | 7/4/2006 | 1/9/2008, 1/10/2008 |
|
User Rating :     / 1
|
Monday, 23 March 2009 08:47 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | JP 2008245601 | A method of preparing a human single-chain variable gene fragment used for producing an antibody library by amplifying the human antibody heavy and light chain gene, digesting fragments and ligatingproducts, and amplifying the variable gene fragment. | Shizuoka-ken (Shizuoka, Japan) | Akiyama Y, Maruyama K | 3/30/2007 | 10/16/2008 | | WO 2008121615 | A new sterile, stable aqueous formulation comprising an antibody or fragment that specifically binds human interferon- , or comprises a 13H5 anti-human interferon- antibody; useful for treating an inflammatory disease. | MedImmune (Gaithersburg, MD, USA) | Bishop S, Wolford JS | 3/30/2007 | 10/9/2008 | | US 20080248050 | A new substance comprising an antibody molecule fragment exhibiting affinity for the target molecule; useful for inducing an immune response against a pathogen and for treating a patient infected with aparticular pathogen. | UChicago Argonne LLC (Chicago) | Stevens FJ | 6/30/2006 | 10/9/2008 | | WO 2008118356 | A new CD154 binding protein and related antibody useful for diagnosing and treating a human condition, disorder or disease mediated in whole or in part by CD40 signaling (e.g., immune, autoimmune orinflammatory response). | Biogen Idec (Cambridge, MA, USA), UCB Pharma (Brussels) | Adams R, Brown DT, Burkly LC, Ferrant-Orgettas JL, Garber EA, Hsu Y, Popplewell AG, Robinson MK, Shock A, Su L, Taylor FR, Tyson KL | 3/22/2007 | 10/2/2008 | | CN 101270163 | A new single-chain fragment antibody-polypeptide fusion protein, where the single chain fragmentantibody is Her2-scFv; useful as an anti-cancersiRNA drug carrier. | Sun Yat-Sen University (Guangzhou, China) | Song E, Yao Y, Zhu P | 4/22/2008 | 9/24/2008 | | WO 2008107260 | A new antibody fragment dimer where the antibody fragments are coupled at their C termini of theheavy chain polypeptides; useful for preparingpharmaceutical compositions for treating diseasesor disorders. | Novo Nordisk (Bagsvaerd, Denmark) | Kjargaard K, Peschke B | 3/5/2007 | 9/12/2008 | | US 20080221309 | A new biologically active recombinant antibody orbiologically active recombinant antibody fragment, used diagnostically/prognostically, therapeutically, for imaging, and/or for affinity purification of MNproteins/polypeptides. | Pastorek J, Pastorekova S, Zavada J | Pastorek J, Pastorekova S, Zavada J | 3/11/1992 | 9/11/2008 | | US 20080213224, WO 2008105740 | A method for identifying and selecting human scFv antibody fragments with specificity for BabA proteinby isolating RNA isolated from peripheral bloodlymphocytes of patients with inhibition-positive serato construct a phage display scFv library. | Boren T, Hammarström L | Boren T, Hammarström L | 3/1/2007 | 9/4/2008 | | WO 2008088983 | New pegylated Abeta antibody fragment, useful for treating or preventing a condition selected from Alzheimer's disease, Down syndrome, stroke, brain hemorrhage or general mental debilitation. | Eli Lilly & Co. (Indianapolis, IN, USA) | Bales KR, Bumol TF, Chow C, Demattos RB, Hansen RJ, Kuchobhotla U, Lu J, McDonnell PC | 1/18/2007 | 7/24/2008 | | WO 2008071009 | New ligand containing block copolymers usefulfor attaching a variety of targeting moieties (e.g., antibodies, peptides, lipids, oligonucleotides, antibody fragments, sugars and peptides). | University of Alberta (Edmonton, Alberta, Canada) | Lavasanifar A, Xiong X | 12/15/2006 | 6/19/2008 |
|
|
Monday, 23 March 2009 08:44 |
| Patent # | Subject | Assignee(s) | Inventor(s) | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | WO 2007034784 | A connective tissue growth factor (CTGF) gene expression inhibitor comprising pyrrole imidazole polyamide having N-methyl pyrrole, N-methyl imidazole and gamma-aminobutryic acid units; useful for treating CTGF-associated disease. | Gentier Biosystems (Tokyo), Nihon University (Tokyo) | Fukuda N, Sugiyama H, Ueno T | 9/20/2005 | 3/29/2007 | | WO 2007035950 | A method of screening a library of RNA interference agents to identify an RNA interference agent or a cocktail of RNA interference agents that can inhibit expression of a first target gene, involving contacting the RNA interference agent or cocktail of RNA interference agents with cells organized in a matrix and detecting a change in expression of the first target gene in the cells or a change in the cells' phenotype. | B-Bridge International (Mountain View, CA, USA) | Eguchi Y, Mizutani T, Shibamoto S | 9/23/2005 | 3/29/2007 | | US 20070036771 | A method of regulating gene expression comprising introducing to gene depositories recombinant virus comprising an expression cassette including the regulatable transcription control element operably linked to an open reading frame of interest. | Cardiac Pacemakers (Minneapolis, MN, USA) | Girouard SD, Heil RW, Qu J, Ross J, Sih HJ, Wagner DO | 8/12/2005 | 2/15/2007 | | US 20070031356 | A method of screening for a compound that modulates an effect of UV irradiation by comparing the gene expression profiles of the cell contacted with thecompound before UV irradiation with those of control cells. | Buchwald HP, Goralczyk R, Hunziker W, Neeb M, Riss G, Seifert N, Steiner G, Wertz K | Buchwald HP, Goralczyk R, Hunziker W, Neeb M, Riss G, Seifert N, Steiner G, Wertz K | 6/30/2006 | 2/8/2007 | | WO 2007045681, EP 1777291 | A method for recovering RNA from a formalin-fixed, paraffin-embedded biological tissue sample for studying gene expression in tumor tissues, involving de-paraffinizing the sample, contacting with a solution containing proteinase K, heating and adding proteinase K. | Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon (Barcelona, Spain) | Rosell Costa RC,Taron Roca MC | 10/20/2005 | 10/19/2006, 10/20/2005 | | WO 2007047706 | A method for inducing expression of a target protein comprising contacting the host cell with an agent, which suppresses the nonsense mutation. This gene regulation method does not rely on the control of transcription; useful in the study of gene expression. | Children's Hospital Medical Center (Boston, MA, USA) | Mulligan R, Murphy GJ | 10/17/2005 | 10/17/2006 | | CN 1844387 | An antisense oligonucleotide structure inhibiting expression of SIRT1 and used for treating lung, hepatic and pancreatic cancers. | Institute of Radiation Medicine (Beijing, PRC) | Bo X, Lin R, Lou S, Sun D, Wang S | 4/26/2006 | 10/11/2006 | | WO 2007039454 | A method of silencing or attenuating expression of a target gene for conferring in plants a trait, e.g., disease resistance by introducing or expressing into the plant a chimeric ribonucleotide sequence comprising a modified ta-siRNA sequence. | BASF Plant Science (Ludwigshafen, Germany) | McMillan J, Ren P, Song H, Wang Y | 9/20/2005 | 9/20/2006 | | US 20070089203 | A new stress-responsive promoter polynucleotide useful in conferring in a plant a desired trait, preferably increased dehydration stress tolerance or increased mechanical stress tolerance. | Bryant CJ, Elborough KM, Phillips JR, Puthigae S, Smith-Espinoza CJ, South CR | Bryant CJ, Elborough KM, Phillips JR, Puthigae S, Smith-Espinoza CJ, South CR | 8/9/2005 | 8/8/2006 | | WO 2007019062 | A new isolated and purified zinc-finger polypeptide comprising a nucleotide binding region of 5 to 10 amino acid residues; useful as a gene expression regulator for treating cancer, for example. | Scripps Research Institute (La Jolla, CA, USA) | Barbas CF, Dreier B | 8/11/2005 | 7/26/2006 |
|
|
Monday, 23 March 2009 08:41 |
| Patent number | Description | Assignee | Inventor | Priority application date | Publication date |
|---|
Source: Thomson Scientific Search Service. The status of each application is slightly different from country to country. For further details, contact Thomson Scientific, 1800 Diagonal Road, Suite 250, Alexandria, Virginia 22314, USA. Tel: 1 (800) 337-9368 (http://www.thomson.com/scientific). | | US 20090013433 | A transgenic plant comprising a brassinosteroid receptor BRI1 kinase inhibitor 1 (BKI1)-type polypeptide or modulator of bki1-type gene expression; useful for displaying modulated brassinosteroid response and plant phenotype. The modulator in the transgenic plant is an RNA interference or antisense molecule that inhibits translation of an mRNA that encodes a BKI1-type polypeptide. | Salk Institute for Biological Sciences (La Jolla, CA, USA) | Chory J, Wang X | 1/10/2007 | 1/8/2009 | | WO 2009002440 | A nucleic acid molecule that downregulates expression of an epidermal growth factor receptor (EGFR) gene via RNA interference; useful for preparing a composition for treating or preventing EGFR-expressing cancer. | Liu Y, Xie FY, Yang X | Liu Y, Xie FY, Yang X | 6/22/2007 | 12/31/2008 | | WO 2008155918 | A method of promoting or inhibiting activity of hypoxia-inducible factor-1 (HIF-1 ), involving increasing or reducing the interaction of intracellular inhibitor of factor inhibiting HIF-1 (iFIH) protein and factor inhibiting HIF-1 (FIH-1) protein, or increasing or reducing the interaction of intracellular membrane type 1–matrix metalloproteinase–cytoplasmic tail binding protein (MT1-MMP-CP) and FIH-1 protein. The interaction of iFIH-1 and FIH-1 protein is reduced by decreasing the expression of iFIH-1 protein by RNA interference. | University of Tokyo (Tokyo) | Sakamoto T, Seiki M | 6/20/2007 | 12/24/2008 | | US 20080311081, WO 2008156702, WO 2008156661 | An invasive bacterium comprising small interfering RNA that interferes with the mRNA of human papilloma virus (HPV) oncogenes; useful for treating or preventing a viral disease or disorder—e.g., HPV infection. | Cequent Pharmaceuticals (Cambridge, MA, USA); Fruehauf J, Laroux FS, Sauer NJ, Vaze MB, Beth Israel Deaconess Medical Center (Boston) | Fruehauf J, Laroux FS, Sauer NJ, Vaze MB, Li C | 6/15/2007 | 12/18/2008, 12/24/2008, 12/24/2008 | | WO 2008152131 | A new RNA interference agent comprising sense strand; useful for treating a human subject afflicted with cystic fibrosis or Liddle syndrome, and for treating and/or preventing hypertension and/or renal insufficiency in a human subject. | Novartis (Basel, Switzerland) | Danahay HL, Geick A, Hickman E, Tan P, van Heeke G, Vornlocher H | 6/15/2007 | 12/18/2008 | | JP 2008301812 | A kit comprising a vector containing a promoter derived from phage used for producing double-stranded RNA having an RNA interference effect in lactic acid bacteria. The lactic acid bacteria are useful in compositions for killing intestinal parasites and treating enteric diseases—e.g., Caenorhabditis and Ascaris. | Okayama University (Japan) | Otsuki T, Shishido M | 5/10/2007 | 12/18/2008 | | WO 2008148304, CN 101314775 | An HIV-targeted RNA interference target sequence; useful for treating HIV infection. | Xiamen University (Xiamen, China); Yang Sheng Tang Co. (Haikou, China) | Cheng T, Miao J, Xia N, Zhang J, Zhang T, Zhang Y | 5/31/2007 | 12/11/2008, 12/3/2008 | | CN 101246169 | A diagnostic reagent for oral squamous cell carcinoma comprising a reagent capable of detecting the expression level of RACK1 protein and its mRNA content; useful for preparing a kit or biochip for oral mucosa carcinoma. The drug comprises an RNA interference molecule of RACK1 protein. | University of Sichuan (China) | Ceng X, Chen Q, Huang C, Wang Z | 5/23/2007 | 8/20/2008 | | JP 2008167739 | A novel modified double-stranded RNA having RNA interference activity, comprising sense strand RNA having a complementary base sequence to a target gene and an antisense strand RNA for suppressing expression of the target gene. | National Institute of Advanced Industrial Science and Technology (Tokyo) | Bakalova R, Kubo T, Oba H, Zhelev Z | 6/14/2006 | 7/24/2008 |
|
|
|